Abstract:Background: Polo-like kinase 1 (PLK1) is an important molecule in proliferation of many human cancers. The aim of study is to clarify the expression patterns and potential function of PLK1 in colorectal cancers. Material/Methods: Fifty-six colorectal cancers samples were collected and arranged onto a tissue array and the expression of PLK1 were detected by immunohistochemistry and correlated with clinico-pathological characteristics and expression of PCNA. Expression of PLK1 in 9 colorectal cancer cells lines was investigated by RT-PCR and Western blot, then SW1116 cells lines were treated with PLK1 siRNA and the efficiency was examined by Western blot. Transwell test was applied to detect the migration and invasion capability of cancer cells by counting the number of cells passing through the membranes. Cell proliferation and apoptosis were examined by Cell Counting Kit-8 (CCK-8) and Annexin-V Kit. Results: PLK1 was positively expressed in 73.2% (41/56) of colorectal cancers tissues, but in only 3.6% (2/56) of normal tissues, and was associated with Duke's stage (P<0.01), tumor size (P<0.01), invasion extent (P<0.05) and lymphatic metastasis (P<0.01). The expression of PLK1 was correlated with expression of PCNA (R=0.553, P<0.01). PLK1 was inhibited in SW1116 cells by treating with PLK1 siRNA oligos, which resulted in a decreased number of cells passing through the membrane as compared with control groups (P<0.01) at 24 hours after transfection. Cell proliferation was inhibited from 48 hours after transfection, while cells apoptosis was induced from 72 hours after transfection. Conclusions: PLK1 could be a progression marker for colorectal cancer patients and PLK1 depletion can inhibit migration and invasion capability of colorectal cancer cells SW1116, suggesting that PLK1 might be involved in metastasis and invasion of colorectal cancer. Therapeutic strategies targeting PLK1 may be a new approach to colorectal cancer.

[Knockdown of PLK1 Mrna by Special Sirna].

Efficient inhibition of human colorectal carcinoma growth by RNA interference targeting polo-like kinase 1 in vitro and in vivo.

Construction of the recombinant adenovirus mediated short hairpin RNA to silence Polo-like kinase 1 and its biomedical application

Influence of Silencing Polo-like Kinase 1 on Migration and Invasion of Colorectal Cancer Cells

Knockdown of STAT3 Expression in SKOV3 Cells by Biodegradable Sirna–plga/cso Conjugate Micelles

[Study of Growth Inhibition of Gastric Cancer Cells by Srna Targeting Polo Like Kinase 1 in Vitro and Vivo].

Effects of selective inactivation of DNA-PKcs gene with small interfering RNA on radiosensitivity of human pancreatic carcinoma cell line

Effects of RNA Interference Polo-Like Kinase-1 Gene on Telomerase Activity of Human Colon Cancer Cell

[Effect of siRNA for mutant p53 gene on biological behavior of gastric cancer cell line SGC7901].

Apoptosis Induction with Polo-Like Kinase-1 Antisense Phosph-Orothioate Oligodeoxynucleotide of Colon Cancer Cell Line SW480

Inhibition of Plk-1 gene expression enhences 5-Fu and CDDP induced apoptosis of gastric cancer cells

Enhanced Chemosensitivity to CPT-11 in Colorectal Carcinoma Xenografts by Small Hairpin RNA Interference Targeting PLK1.

Polo-like kinase 1 is overexpressed in colorectal cancer and participates in the migration and invasion of colorectal cancer cells.

RNA Interference Targeting PLK1 Induced Human Prostatic Carcinoma Cell Line PC-3 Apoptosis

Intravenous Liposomal Delivery of the Short Hairpin RNAs Against Plk1 Controls the Growth of Established Human Hepatocellular Carcinoma.

Inhibitory Effect of Polo-like Kinase 1 Depletion on Mitosis and Apoptosis of Gastric Cancer Cells

miR-296-5p suppresses cell viability by directly targeting PLK1 in non-small cell lung cancer.

Mitosis Arrest Caused by Inhibition of PLK1 Expression in Gastric Cancer MKN45 Cells

Rapid Functional Screening of Effective Sirnas Against Plk1 and Its Growth Inhibitory Effects in Laryngeal Carcinoma Cells.

Involvement of Polo-like Kinase 1 (plk1) in Mitotic Arrest by Inhibition of Mitogen-activated Protein Kinase-Extracellular Signal-regulated Kinase-Ribosomal S6 Kinase 1

[Silencing of Adrm1 by RNA Interference Suppresses Proliferation of Colorectal Cancer Cells].